| Bone disease after kidney transplantation A Bouquegneau, S Salam, P Delanaye, R Eastell, A Khwaja Clinical Journal of the American Society of Nephrology 11 (7), 1282-1296, 2016 | 169 | 2016 |
| Anorexia nervosa and the kidney A Bouquegneau, BE Dubois, JM Krzesinski, P Delanaye American Journal of Kidney Diseases 60 (2), 299-307, 2012 | 108 | 2012 |
| Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis A Bouquegneau, C Loheac, O Aubert, Y Bouatou, D Viglietti, JP Empana, ... PLoS medicine 15 (5), e1002572, 2018 | 103 | 2018 |
| Creatinine‐based equations for the adjustment of drug dosage in an obese population A Bouquegneau, E Vidal‐Petiot, O Moranne, C Mariat, JJ Boffa, ... British journal of clinical pharmacology 81 (2), 349-361, 2016 | 71 | 2016 |
| Modification of Diet in Renal Disease versus Chronic Kidney Disease Epidemiology Collaboration equation to estimate glomerular filtration rate in obese patients A Bouquegneau, E Vidal-Petiot, F Vrtovsnik, E Cavalier, M Rorive, ... Nephrology Dialysis Transplantation 28 (suppl_4), iv122-iv130, 2013 | 60 | 2013 |
| Biomarkers and physiopathology in the cardiorenal syndrome A Bouquegneau, JM Krzesinski, P Delanaye, E Cavalier Clinica Chimica Acta 443, 100-107, 2015 | 55 | 2015 |
| Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study G Darcis, A Bouquegneau, N Maes, M Thys, M Henket, F Labye, ... International Journal of Infectious Diseases 109, 209-216, 2021 | 53 | 2021 |
| Proteinuria in COVID-19: prevalence, characterization and prognostic role J Huart, A Bouquegneau, L Lutteri, P Erpicum, S Grosch, G Résimont, ... Journal of nephrology 34, 355-364, 2021 | 48 | 2021 |
| Assessment of the utility of kidney histology as a basis for discarding organs in the United States: a comparison of international transplant practices and outcomes PP Reese, O Aubert, M Naesens, E Huang, V Potluri, D Kuypers, ... Journal of the American Society of Nephrology 32 (2), 397-409, 2021 | 44 | 2021 |
| Discrepancies between the Cockcroft–gault and chronic kidney disease epidemiology (CKD-EPI) equations: implications for refining drug dosage adjustment strategies P Delanaye, F Guerber, A Scheen, T Ellam, A Bouquegneau, D Guergour, ... Clinical pharmacokinetics 56, 193-205, 2017 | 33 | 2017 |
| Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know P Delanaye, F Paquot, A Bouquegneau, F Blocki, JM Krzesinski, ... Nephrology Dialysis Transplantation 33 (8), 1404-1410, 2018 | 31 | 2018 |
| COVID-19–associated nephropathy includes tubular necrosis and capillary congestion, with evidence of SARS-CoV-2 in the nephron A Bouquegneau, P Erpicum, S Grosch, L Habran, O Hougrand, J Huart, ... Kidney360 2 (4), 639-652, 2021 | 30 | 2021 |
| Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2. L Firket, J Descy, L Seidel, C Bonvoisin, A Bouquegneau, S Grosch, ... American journal of transplantation: official journal of the American …, 2021 | 25 | 2021 |
| Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemic J Guiot, M Henket, AN Frix, M Delvaux, A Denis, L Giltay, M Thys, F Gester, ... Respiratory investigation 58 (6), 437-439, 2020 | 20 | 2020 |
| Sclerostin within the chronic kidney disease spectrum A Bouquegneau, P Evenepoel, F Paquot, O Malaise, E Cavalier, ... Clinica Chimica Acta 502, 84-90, 2020 | 15 | 2020 |
| Sclerostin levels in CKD patients: an important, but not definitive, step on the way to clinical use P Delanaye, E Cavalier, A Bouquegneau, A Khwaja Kidney International 88 (6), 1221-1223, 2015 | 13 | 2015 |
| Diagnostic yield of 18F-FDG PET/CT imaging and urinary CXCL9/creatinine levels in kidney allograft subclinical rejection O Hanssen, L Weekers, P Lovinfosse, A Jadoul, C Bonvoisin, ... American Journal of Transplantation 20 (5), 1402-1409, 2020 | 12 | 2020 |
| Estimation of glomerular filtration rate for drug dosing in patients with very high or low body mass index EM Donker, P Bet, A Nurmohamed, E Serné, GL Burchell, AN Friedman, ... Clinical and Translational Science 15 (9), 2206-2217, 2022 | 10 | 2022 |
| Correction: Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis A Bouquegneau, C Loheac, O Aubert, Y Bouatou, D Viglietti, JP Empana, ... Plos Medicine 15 (7), e1002637, 2018 | 9 | 2018 |
| Age-adapted percentiles of measured glomerular filtration in healthy individuals: extrapolation to living kidney donors over 65 years P Delanaye, F Gaillard, J van der Weijden, G Mjøen, I Ferhman-Ekholm, ... Clinical Chemistry and Laboratory Medicine (CCLM) 60 (3), 401-407, 2022 | 8 | 2022 |
